Jessica Flanigan, assistant professor of leadership studies and philosophy, politics, economics and law, argues for a broader risk-benefit calculus for prescribing stimulants.

Flanigan states, "...if it’s possible to judge that, on balance, it’s a benefit to take stimulants in those cases, it seems conceivable that the risk-benefit calculus could come out in favor of stimulus for students who face other kinds of cognitive impairments." Read the full interview in Quartz.

Associate Professor of Leadership Studies and Philosophy, Politics, Economics and Law
Political Philosophy